After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that MacroGenics to Participate in Upcoming Investor Conferences.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Macrogenics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $20.64 and fluctuated between $21.33 as its day high and $20.28 as its day low. The current market capitalization of Macrogenics Inc is $1.28B. A total of 2.31 million shares were traded on the day, compared to an average of 1.08M shares.
Insider Activity
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, MGNX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 3 BUYs and 1 SELLs from insiders. Insiders purchased 365,000 shares during that period but sold 5,372.
In the most recent transaction, Peters Jeffrey Stuart sold 16,124 shares of MGNX for 17.22 per share on Feb 26. After the transaction, the Senior VP and General Counsel now owns 8,895 company shares. In a previous transaction on Feb 07, Bonvini Ezio sold 3,334 shares at 18.00 per share. MGNX shares that Sr VP, Research & CSO owns now total 71,334.
Among the insiders who sold shares, Peters Jeffrey Stuart disposed of 76,251 shares on Feb 05 at a per-share price of $16.50. This resulted in the Senior VP and General Counsel holding 0 shares of MGNX after the transaction. In another insider transaction, Bonvini Ezio sold 13,316 shares at $15.00 per share on Feb 01. Company shares held by the Sr VP, Research & CSO now total 74,668.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, MGNX has a high of $20.80 and a low of $4.29.
As of this writing, MGNX has an earnings estimate of -$0.15 per share for the current quarter. EPS was calculated based on a consensus of 10 estimates, with a high estimate of $0.38 per share and a lower estimate of -$0.37. The company reported an EPS of $0.92 in the last quarter, which was 276.90% higher than expectations of -$0.52.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. MGNX’s latest balance sheet shows that the firm has $243.62M in Cash & Short Term Investments as of fiscal 2021. There were $25.47M in debt and $74.58M in liabilities at the time. Its Book Value Per Share was $3.13, while its Total Shareholder’s Equity was $239.62M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MGNX is Buy with a score of 4.45.
